AAX Biotech Selected as Finalist for Nordic Star 2025 Pitch Competition

We are proud to announce that AAX Biotech has been selected as one of 14 finalists for the Nordic Star 2025 Pitch Competition at Nordic Life Science Days (NLSDays), taking place in Gothenburg on October 13–14, 2025.

The Nordic Star competition highlights some of the most promising emerging life science companies in the region. Being included among this year’s finalists is an exciting opportunity for us to showcase how our platforms — Seqitope®, for high-resolution epitope mapping, and Opti-mAb®, for stabilizing and optimizing antibody fragments — are helping accelerate the development of next-generation precision antibody therapeutics.

We are looking forward to taking the stage alongside other inspiring innovators, sharing our vision, and connecting with potential partners and investors who are shaping the future of life sciences.

If you are attending NLSDays and would like to learn more about how our technologies are addressing key challenges in antibody drug development, we’d love to connect in Gothenburg.